Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including ...
Avitar reported revenue of $3.11 million for fiscal year 2007, down 31.3% from fiscal year 2006, and net income of -$2.41 million. In Q1 2008 (the quarter ended December 31, 2007) revenue was $505,386, down 46.7% from a year before. Its market capitalization was $20,558 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2007; market data as of October 8, 2026.
No profile data available.